Medtronic plc vs Johnson & Johnson
MDT vs JNJ — side-by-side comparison from reported financials. MDT leads 3, JNJ leads 6 of 9 comparable metrics.
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MDT | JNJ |
|---|---|---|
| Price | $88.01 | $261.79 |
| Market cap | $113B | $631B |
| Revenue (TTM) | $37.5B | $97.9B |
| Revenue growth | +5.2% | +5.6% |
| Net margin | 13.9% | 21.5% |
| Free cash flow | $6.13B | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | -8.8% | +37.0% |
| P/E | 21.6 | 29.9 |
| P/E vs own history (cheap-side %) | 96% | 16% |
| Dividend yield | 3.22% | 2.00% |
| Return on equity | 11% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 95,000 | 140,800 |
Full résumé-style profiles: MDT CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.